产品目录

N-((1,2,3,5,6,7-六氢-s-indacen-4-基)氨基甲酰基)-1-异丙基-1H-吡唑-3-磺酰胺

Emlenoflast

- - 98%

N-((1R,2R,3S)-2-羟基-3-(10H-吩恶嗪-10-基)环己基)-4-(三氟甲氧基)苯磺酰胺

DT-061

- - 99%

1-(4-氟苯基)-N-甲基-N-(4-(3-苯基脲基)苯基)-1H-吡唑-4-磺酰胺

BTT 3033

- - 99%

COX-2抑制剂6

COX-2-IN-6

- - 99%

化合物 T28497

RA839

- - 99%

(2Z,5Z)-5-(3-氯-4-((R)-2,3-二羟基丙氧基)亚苄基)-2-(丙亚胺基)-3-(邻甲苯基)噻唑烷-4-酮

PONESIMOD

- - 98%

6-(4-((5-氧代-1,2,3,4,5,6-六氢苯并[h][1,6]萘啶-8-基)甲基)哌嗪-1-基)吡啶-3-甲腈

JPI-547

- - 98%

(2'S)-3-氯-4-((3,5-二氟吡啶-2-基)甲氧基)-2'-(2-(2-羟基丙烷-2-基)嘧啶-4-基)-5',6-二甲基-2H-[1,4'-联吡啶]-2-酮

ZUNSEMETINIB

- - 99%

化合物LY2562175

LY-2562175

- - 99%

3-(4-溴苯基)-6-((4-(4-甲氧基苯基)哌嗪-1-基)甲基)噻唑并[2,3-c][1,2,4]三唑

FSEN1

- - 98%

1-乙基-3-吗啉-5,6,7,8-四氢异喹啉-4-甲腈

mGluR3 modulator-1

- - 99%

反式-4-(3-(羟甲基)苯氧基)-N-甲基-N-(3-甲基-4-(((S)-3-甲基哌嗪-1-基)甲基)苯基)环己烷-1-甲酰胺

Unii-5H2DV04I6O

- - 98%

(S)-2-((9-异丙基-6-((4-(吡啶-2-基)苄基)氨基)-9H-嘌呤-2-基)氨基)丁-1-醇

(S)-CR8

- - 98%

6-(2,6-二氯苯基)-8-甲基-2-((4-吗啉基苯基)氨基)吡啶并[2,3-d]嘧啶-7(8H)-酮

PD 173952

- - 97%

(E)-4,6-二氯-3-(3-氧代-3-(苯基氨基)丙-1-烯-1-基)-1H-吲哚-2-羧酸钠

GAVESTINEL

- - 99%

(3S,4R)-4-((5-氯-4-(4-氟-2-(2-羟基丙-2-基)-1-异丙基-1H-苯并[d]咪唑-6-基)嘧啶-2-基)氨基)四氢-2H-吡喃-3-醇

CDK4/6-IN-6

- - 98%

1-(4-(5'-氯-3,5-二甲基-[2,4'-联吡啶]-2'-基)哌嗪-1-基)-3-(甲磺酰基)丙-1-酮 盐酸盐

PF-05274857 HCl

- - 98%

2,2'-(萘-1,4-二基双(((4-甲氧基苯基)磺酰基)氮杂二基))二乙酸

CPUY192018

- - 99%

化合物 T11035

DIABZI STING AGONIST-1 (TAUTOMERISM)

- - 99%

2-(2-(4-(2-甲氧基苯基)哌嗪-1-基)乙基)-4,4-二甲基异喹啉-1,3(2H,4H)-二酮

ARC 239

- - 97%